|
A more recent version of this article appeared on November 1, 2004
Papers In Press, published online ahead of print August 16, 2004
J. Lipid Res., doi:10.1194/jlr.M400049-JLR200
Submitted on February 9, 2004
Revised on July 27, 2004
Accepted on August 15, 2004
Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism
Gemma Llaverias, Manuel Vázquez-Carrera, Rosa M. Sánchez, Véronique Noé, Carlos J. Ciudad, Juan C. Laguna, and Marta Alegret
Department of Pharmacology, University of Barcelona, School of Pharmacy, Barcelona, Barcelona 08028
Corresponding Author: alegret{at}ub.edu
Peroxisome proliferator-activated receptor g (PPARg) activation or overexpression induce caveolin-1 expression in several cell types. The objective of this study was to investigate if PPAR agonists could also regulate the caveolin-1 gene in macrophages, and to explore the mechanisms involved. Our experiments demonstrated that rosiglitazone dose- and time-dependently increased caveolin-1 mRNA and protein in THP-1 macrophages. This induction was not observed in the presence of inhibitors of transcription or de novo protein synthesis. We also showed that the increase in caveolin-1 elicited by rosiglitazone was not related either to macrophage differentiation or to cellular apoptosis. The inductive effect seems to be dependent on PPAR activation, as the PPAR antagonist GW9662 abolished it. The activation of the liver X receptor (LXR) with 22(R)-hydroxycholesterol also increased caveolin-1 mRNA, while the inactive (S) isomer did not. Finally, we identified a functional peroxisome proliferator response element (PPRE) in the caveolin-1 promoter, which was activated upon rosiglitazone treatment in THP-1 macrophages.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Rigamonti, G. Chinetti-Gbaguidi, and B. Staels
Regulation of Macrophage Functions by PPAR-{alpha}, PPAR-{gamma}, and LXRs in Mice and Men
Arterioscler Thromb Vasc Biol,
June 1, 2008;
28(6):
1050 - 1059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Le Saux, K. Teeters, S. K. Miyasato, P. R. Hoffmann, O. Bollt, V. Douet, R. V. Shohet, D. H. Broide, and E. K. Tam
Down-regulation of Caveolin-1, an Inhibitor of Transforming Growth Factor-{beta} Signaling, in Acute Allergen-induced Airway Remodeling
J. Biol. Chem.,
February 29, 2008;
283(9):
5760 - 5768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chintharlapalli, S. Papineni, I. Jutooru, A. McAlees, and S. Safe
Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells
Mol. Cancer Ther.,
May 1, 2007;
6(5):
1588 - 1598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Frank, M. W.-C. Cheung, S. Pavlides, G. Llaverias, D. S. Park, and M. P. Lisanti
Caveolin-1 and regulation of cellular cholesterol homeostasis
Am J Physiol Heart Circ Physiol,
August 1, 2006;
291(2):
H677 - H686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J Deckelbaum, T. S Worgall, and T. Seo
n-3 Fatty acids and gene expression
Am. J. Clinical Nutrition,
June 1, 2006;
83(6):
S1520 - 1525S.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|